CLASS II ONGOING Device recall · Reported 21 May 2025 · FDA Enforcement Report

FoundationOne Companion Diagnostic (F1CDx) recalled

Foundation Medicine is recalling FoundationOne Companion Diagnostic (F1CDx), distributed nationwide in the US. The recall was initiated on 9 Apr 2025 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesORD-XXXXX28-01 ORD-XXXXX98-01 ORD-XXXXX29-01 ORD-XXXXX99-01 Note: The above characters have been redacted to minimize patient information disclosure.
Quantity recalled4 units

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1747-2025
FDA event ID
96621
Recalling firm
Foundation Medicine, Cambridge, MA
Classification
Class II
Status
Ongoing
Recall initiated
9 Apr 2025
FDA classified
12 May 2025
Reported
21 May 2025
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons

Timeline

9 Apr 2025Recall initiated by company
12 May 2025Classified by FDA+33 days
21 May 2025Published in enforcement report+9 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Four (4) total reports were sent to customers with clinically relevant variants requiring amendment, one (1) of which with an incorrect negative CDx claim. The remaining three (3) with tumor profiling result changes did not impact CDx indications.

Product as listed by the FDA

FoundationOne Companion Diagnostic (F1CDx)

Where it was distributed

Worldwide - US Nationwide distribution in the states of GA, NY and the country of Russia.

Nationwide GeorgiaNew York

Questions about this recall

Why was it recalled?

Four (4) total reports were sent to customers with clinically relevant variants requiring amendment, one (1) of which with an incorrect negative CDx claim. The remaining three (3) with tumor profiling result changes did not impact CDx indications.

Which lots are affected?

ORD-XXXXX28-01 ORD-XXXXX98-01 ORD-XXXXX29-01 ORD-XXXXX99-01 Note: The above characters have been redacted to minimize patient information disclosure.

Where was it sold?

Worldwide - US Nationwide distribution in the states of GA, NY and the country of Russia.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Foundation Medicine

All 10

Other Test Kits & Diagnostics recalls

All 2,656